Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference62 articles.
1. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus;Passweg;Bone Marrow Transplant,2020
2. Current Use and Trends in Hematopoietic Cell Transplantation in the United States;D’Souza;Biol Blood Marrow Transplant,2017
3. Bortezomib for myeloma – much ado about something;Dispenzieri;N Engl J Med,2005
4. Daratumumab: a game changer in myeloma therapy;Ludwig;Lancet Haematol,2020
5. Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma;Martino;Expert Opin Investig Drugs,2013
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Policy and perspective on outpatient programs for autologous hematopoietic cell transplantation and immune-effector cell therapy administration;Frontiers in Immunology;2024-08-06
2. Ambulatory models for autologous stem-cell transplantation: a systematic review of the health impact;Frontiers in Immunology;2024-07-16
3. Optimizing autologous stem cell transplantation for multiple myeloma: early step-down ward vs. HEPA-filtered room settings – a practical approach for resource-constrained settings;2024-05-29
4. At-Home HCT;The EBMT Handbook;2024
5. Aiming for the cure in myeloma: Putting our best foot forward;Blood Reviews;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3